Cardioprotective role of a magnolol and honokiol complex in the prevention of doxorubicin-mediated cardiotoxicity in adult rats.

[1]  Y. Olgar,et al.  Intracellular Redistribution of Left Ventricular Connexin 43 Contributes to the Remodeling of Electrical Properties of the Heart in Insulin-resistant Elderly Rats , 2022, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[2]  H. Aukema,et al.  Comparing Flaxseed and Perindopril in the Prevention of Doxorubicin and Trastuzumab-Induced Cardiotoxicity in C57Bl/6 Mice , 2022, Current oncology.

[3]  M. A. Ayza,et al.  Potential Protective Effects of Antioxidants against Cyclophosphamide-Induced Nephrotoxicity , 2022, International journal of nephrology.

[4]  Shuai Yi,et al.  Effect of Traditional Chinese Medicine on the Cardiovascular Diseases , 2022, Frontiers in Pharmacology.

[5]  D. Rizopoulos,et al.  Dynamic personalized risk prediction in chronic heart failure patients: a longitudinal, clinical investigation of 92 biomarkers (Bio-SHiFT study) , 2022, Scientific Reports.

[6]  M. Karahan,et al.  Prevention of doxorubicin-induced experimental cardiotoxicity by Nigella sativa in rats. , 2022, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[7]  Katarzyna Szałabska-Rąpała,et al.  Effectiveness of Magnolol, a Lignan from Magnolia Bark, in Diabetes, Its Complications and Comorbidities—A Review , 2021, International journal of molecular sciences.

[8]  Yanfeng Wang,et al.  Protective Effects of Estrogen on Cardiovascular Disease Mediated by Oxidative Stress , 2021, Oxidative medicine and cellular longevity.

[9]  Xiaolan Qu,et al.  Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update , 2021, Frontiers in Pharmacology.

[10]  H. Hua,et al.  Discovery of β-carboline-(phenylsulfonyl)furoxan hybrids as potential anti-breast cancer agents. , 2021, Bioorganic & medicinal chemistry letters.

[11]  T. Zeller,et al.  Biomarkers for Heart Failure Prognosis: Proteins, Genetic Scores and Non-coding RNAs , 2020, Frontiers in Cardiovascular Medicine.

[12]  D. Al-disi,et al.  Doxorubicin-induced alterations in kidney functioning, oxidative stress, DNA damage, and renal tissue morphology; Improvement by Acacia hydaspica tannin-rich ethyl acetate fraction , 2020, Saudi journal of biological sciences.

[13]  H. Aukema,et al.  The Cardioprotective Role of Flaxseed in the Prevention of Doxorubicin- and Trastuzumab-Mediated Cardiotoxicity in C57BL/6 Mice. , 2020, The Journal of nutrition.

[14]  C. Hölscher,et al.  Magnolol alleviates Alzheimer's disease-like pathology in transgenic C. elegans by promoting microglia phagocytosis and the degradation of beta-amyloid through activation of PPAR-γ. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[15]  S. Colan,et al.  Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors , 2019, Cardio-oncology.

[16]  B. Kalyanaraman.  Teaching the basics of the mechanism of doxorubicin-induced cardiotoxicity: Have we been barking up the wrong tree? , 2019, Redox biology.

[17]  M. Rabei,et al.  Effect of ghrelin on VEGF-B and connexin-43 in a rat model of doxorubicin-induced cardiomyopathy , 2019, Journal of basic and clinical physiology and pharmacology.

[18]  L. Chen,et al.  P Wave Indices—Advancing Our Understanding of Atrial Fibrillation-Related Cardiovascular Outcomes , 2019, Front. Cardiovasc. Med..

[19]  Antiño R. Allen,et al.  Effects of Cyclophosphamide and/or Doxorubicin in a Murine Model of Postchemotherapy Cognitive Impairment , 2018, Toxicological sciences : an official journal of the Society of Toxicology.

[20]  D. Bravo,et al.  Growth-Promoting and Antioxidant Effects of Magnolia Bark Extract in Chickens Uninfected or Co-Infected with Clostridium perfringens and Eimeria maxima as an Experimental Model of Necrotic Enteritis , 2018, Current developments in nutrition.

[21]  A. Durak,et al.  Onset of decreased heart work is correlated with increased heart rate and shortened QT interval in high-carbohydrate fed overweight rats. , 2017, Canadian journal of physiology and pharmacology.

[22]  V. Salemi,et al.  Vitamin C mitigates oxidative/nitrosative stress and inflammation in doxorubicin-induced cardiomyopathy. , 2017, American journal of physiology. Heart and circulatory physiology.

[23]  A. De Angelis,et al.  Effects of ranolazine in a model of doxorubicin‐induced left ventricle diastolic dysfunction , 2017, British journal of pharmacology.

[24]  Elsayed Z Soliman,et al.  Relation of Prolonged P-Wave Duration to Risk of Sudden Cardiac Death in the General Population (from the Atherosclerosis Risk in Communities Study). , 2017, The American journal of cardiology.

[25]  K. Kohli,et al.  Folic acid ameliorates celecoxib cardiotoxicity in a doxorubicin heart failure rat model , 2017, Pharmaceutical biology.

[26]  Jeff Scholten,et al.  Magnolia officinalis (Hou Po) bark extract stimulates the Nrf2-pathway in hepatocytes and protects against oxidative stress. , 2016, Journal of ethnopharmacology.

[27]  D. Jassal,et al.  The Cardioprotective Role of N-Acetyl Cysteine Amide in the Prevention of Doxorubicin and Trastuzumab-Mediated Cardiac Dysfunction. , 2016, The Canadian journal of cardiology.

[28]  Xianting Ding,et al.  Protective effects of madecassoside against Doxorubicin induced nephrotoxicity in vivo and in vitro , 2015, Scientific Reports.

[29]  D. Stewart,et al.  Antioxidants in Cardiovascular Therapy: Panacea or False Hope? , 2015, Front. Cardiovasc. Med..

[30]  D. Bajić,et al.  Heart rate dynamics in doxorubicin-induced cardiomyopathy , 2015, Physiological measurement.

[31]  Dean P. Jones,et al.  Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial SIRT3 , 2015, Nature Communications.

[32]  Wei Zhang,et al.  Magnolol Administration in Normotensive Young Spontaneously Hypertensive Rats Postpones the Development of Hypertension: Role of Increased PPAR Gamma, Reduced TRB3 and Resultant Alleviative Vascular Insulin Resistance , 2015, PloS one.

[33]  S. Shaikh,et al.  Do fish oil omega-3 fatty acids enhance antioxidant capacity and mitochondrial fatty acid oxidation in human atrial myocardium via PPARγ activation? , 2014, Antioxidants & redox signaling.

[34]  L. Cai,et al.  The Magnolia Bioactive Constituent 4-O-Methylhonokiol Protects against High-Fat Diet-Induced Obesity and Systemic Insulin Resistance in Mice , 2014, Oxidative medicine and cellular longevity.

[35]  O. Bang,et al.  Antioxidant Effects of Statins in Patients with Atherosclerotic Cerebrovascular Disease , 2014, Journal of clinical neurology.

[36]  R. D. de Vos,et al.  Interactions of black tea polyphenols with human gut microbiota: implications for gut and cardiovascular health. , 2013, The American journal of clinical nutrition.

[37]  Ling Wei,et al.  Neuro-Modulating Effects of Honokiol: A Review , 2013, Front. Neurol..

[38]  J. Trochu,et al.  Increased Beta2-Adrenoceptors in Doxorubicin-Induced Cardiomyopathy in Rat , 2013, PloS one.

[39]  L. Lazarenko,et al.  Doxorubicin dose for congestive heart failure modeling and the use of general ultrasound equipment for evaluation in rats. Longitudinal in vivo study. , 2013, Medical ultrasonography.

[40]  Zai-Qun Liu,et al.  Comparison of antioxidant abilities of magnolol and honokiol to scavenge radicals and to protect DNA. , 2011, Biochimie.

[41]  D. Jassal,et al.  The cardioprotective role of probucol against anthracycline and trastuzumab-mediated cardiotoxicity. , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[42]  R. Schulz,et al.  Antioxidant treatment protects diabetic rats from cardiac dysfunction by preserving contractile protein targets of oxidative stress. , 2010, The Journal of nutritional biochemistry.

[43]  G. Lopaschuk,et al.  Metabolic remodeling associated with subchronic doxorubicin cardiomyopathy. , 2010, Toxicology.

[44]  Gui-ping Zhang,et al.  Effects of chronic treatment with honokiol in spontaneously hypertensive rats. , 2010, Biological & pharmaceutical bulletin.

[45]  S. De Flora,et al.  Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention , 2010, Journal of the National Cancer Institute.

[46]  Norman Honbo,et al.  Doxorubicin Cardiomyopathy , 2009, Cardiology.

[47]  M. Frenneaux,et al.  Antioxidant treatment for heart failure: friend or foe? , 2009, QJM : monthly journal of the Association of Physicians.

[48]  A. Çim,et al.  Protective effect of N-acetylcysteine, caffeic acid and vitamin E on doxorubicin hepatotoxicity , 2007, Human & experimental toxicology.

[49]  G. Takemura,et al.  Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management. , 2007, Progress in cardiovascular diseases.

[50]  M. Ilhan,et al.  Effects of melatonin in reducing the toxic effects of doxorubicin , 2006, Molecular and Cellular Biochemistry.

[51]  D. Newby,et al.  Depressed glutathione synthesis precedes oxidative stress and atherogenesis in Apo-E(-/-) mice. , 2005, Biochemical and biophysical research communications.

[52]  Mei Sun,et al.  Antioxidant activity and phenolic compounds of 112 traditional Chinese medicinal plants associated with anticancer , 2004, Life Sciences.

[53]  S. Larsson,et al.  Multivitamin supplements are inversely associated with risk of myocardial infarction in men and women--Stockholm Heart Epidemiology Program (SHEEP). , 2003, The Journal of nutrition.

[54]  S. Swain,et al.  Congestive heart failure in patients treated with doxorubicin , 2003, Cancer.

[55]  L. Hung,et al.  Antiarrhythmic Effect of Magnolol and Honokiol during Acute Phase of Coronary Occlusion in Anesthetized Rats: Influence of L-NAME and Aspirin , 1999, Pharmacology.

[56]  C. Hong,et al.  MAGNOLOL REDUCES INFARCT SIZE AND SUPPRESSES VENTRICULAR ARRHYTHMIA IN RATS SUBJECTED TO CORONARY LIGATION , 1996, Clinical and experimental pharmacology & physiology.

[57]  Y. Lo,et al.  Magnolol and honokiol isolated from Magnolia officinalis protect rat heart mitochondria against lipid peroxidation. , 1994, Biochemical pharmacology.

[58]  P. Singal,et al.  Subcellular effects of adriamycin in the heart: a concise review. , 1987, Journal of molecular and cellular cardiology.

[59]  D. V. Von Hoff,et al.  Risk factors for doxorubicin-induced congestive heart failure. , 1979, Annals of internal medicine.

[60]  E. Benjamin,et al.  P wave duration is associated with cardiovascular and all-cause mortality outcomes: the National Health and Nutrition Examination Survey. , 2011, Heart rhythm.

[61]  S. Weintraub,et al.  Identification of magnolol and honokiol as anxiolytic agents in extracts of saiboku-to, an oriental herbal medicine. , 1998, Journal of natural products.